Medipattern Closes First Tranche of Previously Announced Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Attention: Business/Financial Editors 

The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE:MKI),
is pleased to announce that it has closed the first tranche of financing under
the term debt facility (the "Facility") arranged on November 7, 2012.


Medipattern issued $154,000 of secured notes under the Facility (the "Notes").
The Notes mature on June 30, 2013, and will bear interest at the rate of 6% per
annum, calculated monthly and payable at maturity. The Notes are secured by a
general security agreement over all the assets of the Company, in priority to
all existing security interests granted by the Company. The Notes are subject to
certain redemption and repayment rights. Medipattern and its Board have agreed
to appoint up to two (2) representatives as directors to the Company's Board as
designated by the holders of the notes. The Notes are subject to a four month
and one day resale restriction. 


Further to the closing, Medipattern is pleased to update its shareholders that
it has recently redoubled its efforts relating to the commercialization and
support of its Visualize: Vascular(TM) product platform. In conjunction with
this effort, the Company has retained additional sales and customer service
staff in the greater New York area dedicated to supporting the growing
Visualize: Vascular(TM) customer base. In addition to the expansion of the sales
team, the Company is also pleased to announce that it has successfully launched
its new cloud based data transfer platform. The new system has thus far been
well received by the Company's clients and it is anticipated that the new
service will not only enhance the customer experience but also reduce the
Company's direct operating costs moving forward. 


The securities offered in the placement have not been and will not be registered
under the United States Securities Act of 1933, as amended, (the "U.S.
Securities Act"), and may not be offered or sold within the United States or to,
or for the account or benefit of U.S. persons except in certain transactions
exempt from the registration requirements of the U.S. Securities Act.


About the Medipattern Corporation:

Medipattern(R) is an award-winning leader in the development and
commercialization of healthcare solutions that positively impact people's lives
through the prevention of disease and analysis of medical images and data.
Medipattern's Knowledge-based Informatics (MKI) platform enables delivery of
these streamlined solutions. Medipattern mHealth uses patented prevention
technologies to engage, coach and monitor people in achieving their personalized
goals. Medipattern iaHealth uses patented pattern recognition technology to
analyze medical data to aid medical practitioners in the assessment of disease
and critical anatomy. For more information, please visit the Company's website:
www.medipattern.com.


Medipattern(R) is registered trademarks of The Medipattern Corporation.
Visualize:Vascular(TM) is a registered trademark of Medipattern.


Forward-looking statements 

This document contains forward-looking statements relating to Medipattern's
performance, operations, or business environment. These statements are based on
what we believe are reasonable assumptions given currently available information
and our understanding of Medipattern's current activities. We have tried,
whenever possible, to identify these forward-looking statements using words such
as "anticipates," "believes," "estimates," "expects," "plans," "intends,"
"potential," and similar expressions. Forward-looking statements are not
guarantees of future performance and involve risks and uncertainties that are
difficult to predict or control. A number of factors could cause actual outcomes
and results to differ materially from those expressed in forward-looking
statements. These factors include but are not limited to those set forth in the
Company's corporate filings, (posted at www.sedar.com). These factors should be
considered carefully, and readers should not place undue reliance on
Medipattern's forward-looking statements. In addition, these forward-looking
statements relate to the date on which they are made. The Company disclaims any
intention or obligation to update or revise any forward-looking statements for
any reason. Readers should not rely on forward-looking statements.


FOR FURTHER INFORMATION PLEASE CONTACT: 
The Medipattern Corporation
Jeff Collins
CEO
[phone] ext. 224
[e-mail]
www.medipattern.com


Spinnaker Capital Markets Inc.
Kevin O'Connor
[phone] ext. 226
[e-mail]